Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System In Men With Symptomatic Benign Prostatic Hyperplasia

NCT06965582 is registered in ClinicalTrials.gov with ALPFA Medical as lead sponsor.

NCT NCT06965582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System In Men With Symptomatic Benign Prostatic Hyperplasia
Lead sponsor
ALPFA Medical
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 7, 2025
Completion date
March 31, 2030
Enrollment
100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia